Overview

A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL

Status:
NOT_YET_RECRUITING
Trial end date:
2027-03-01
Target enrollment:
Participant gender:
Summary
Research purpose To evaluate the efficacy and safety of R-mini-MCOP in first-line treatment of primary treatment of diffuse large B-cell lymphoma (DLBCL) in elderly patients Experimental design Single-arm, multicenter, prospective study
Phase:
PHASE2
Details
Lead Sponsor:
Xiaohui He
Collaborator:
CSPC Ouyi Pharmaceutical Co., Ltd.
Treatments:
Cyclophosphamide
Prednisone
Vincristine